Financial statements Kolopharma
Balance sheet data of KOLOPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 473 694,85 | 511 842,93 | 1 832 932,02 | 1 903 416,49 | 2 509 005,64 | 1 842 414,33 |
| A. Fixed assets | 350 000,00 | 333 458,37 | 391 526,90 | 379 298,94 | 367 799,34 | 0,00 |
| B. Current assets | 123 694,85 | 178 384,56 | 1 441 405,12 | 1 524 117,55 | 2 141 206,30 | 1 842 414,33 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 473 694,85 | 511 842,93 | 1 832 932,02 | 1 903 416,49 | 2 509 005,64 | 1 876 260,62 |
| A. Equity | 48 991,13 | 57 691,01 | 1 156 825,36 | 1 598 881,63 | 2 293 577,19 | 1 547 282,63 |
| B. Liabilities and provisions for liabilities | 424 703,72 | 454 151,92 | 661 539,02 | 304 534,86 | 215 428,45 | 328 977,99 |
| I. Long-term liabilities | 259 551,69 | 259 551,69 | - | - | - | - |
| II. Short-term liabilities | 160 649,03 | 183 239,31 | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.